Cockwell,Paul

Institution: University of Birmingham, UK

Top Collaborators: Hutchison CA, Cook M, Basnayake K, Stringer S, Ferro C, Bradwell AR, Dutton M, Basu S, Kubal C, Ng K, Harding S, Moore J, Kaur O, Hattersley J, Neil D, Chapple I, Evans ND, Ball S, Dietrich T, Chappel MJ

Research Interests: Kidney, Disease, Light, Kidney Disease, Patients, Immunoglobulin, Injury, Mortality, Chemotherapy, Dialysis, Multiple Myeloma, Serum, Acute Kidney Injury, Inflammation, Morbidity, Population, Acute Renal Failure, Concentrations, Hemodialysis, Renal Failure

Information and abstracts for author publications
Published Date	Impact	Publication
09/29/2009	7.1	Nature reviews. Nephrology Serum free light chain assessment in monoclonal gammopathy and kidney disease.	Abstract
04/13/2011	6.6	Kidney international The biology of immunoglobulin free light chains and kidney injury.	Abstract
10/27/2011	5.2	Clinical journal of the American Society of Nephrology : CJASN Serum free light chains and the risk of ESRD and death in CKD.	Abstract
04/01/2009	5.2	Clinical journal of the American Society of Nephrology : CJASN Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis.	Abstract
08/31/2011	4.1	PloS one KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation.	Abstract
08/27/2012	3	Advances in chronic kidney disease Achieving an early myeloma response in patients with kidney impairment.	Abstract
09/29/2010	2.3	Journal of clinical pathology Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney.	Abstract
04/25/2013	2.2	BMC nephrology The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol.	Abstract
10/10/2013	2.2	BMC nephrology Optimising the accuracy of blood pressure monitoring in chronic kidney disease: the utility of BpTRU.	Abstract